聚桂醇注射液治疗下肢静脉曲张微循环专家共识

2020-10-20 中国微循环学会 血管与腔内血管外科杂志.2020,6(5):377-381.

聚桂醇作为泡沫硬化剂在临床已被广泛使用。为进一步规范聚桂醇泡沫硬化治疗下肢浅静脉曲张的操作流程,经中国微循环学会周围血管疾病专业委员会组织国内血管外科专家多次讨论,就治疗具体细节进行深入探讨,并结合该

中文标题:

聚桂醇注射液治疗下肢静脉曲张微循环专家共识

发布机构:

中国微循环学会

发布日期:

2020-10-20

简要介绍:

聚桂醇作为泡沫硬化剂在临床已被广泛使用。为进一步规范聚桂醇泡沫硬化治疗下肢浅静脉曲张的操作流程,经中国微循环学会周围血管疾病专业委员会组织国内血管外科专家多次讨论,就治疗具体细节进行深入探讨,并结合该疾病硬化治疗的国内现状,参考国内、外相关资料,委托中国医学科学院北京协和医学院北京协和医院血管外科就下肢静脉曲张硬化治疗的基本概念、诊断和治疗操作规范等方面达成《聚桂醇注射液治疗下肢静脉曲张微循环专家共识(2020 版)》,供临床参考使用。

 

相关资料下载:
[AttachmentFileName(sort=1, fileName=聚桂醇注射液治疗下肢静脉曲张微循环专家共识_.pdf)] GetToolGuiderByIdResponse(projectId=1, id=44bd31c00199e1f6, title=聚桂醇注射液治疗下肢静脉曲张微循环专家共识, enTitle=, guiderFrom=血管与腔内血管外科杂志.2020,6(5):377-381., authorId=0, author=, summary=聚桂醇作为泡沫硬化剂在临床已被广泛使用。为进一步规范聚桂醇泡沫硬化治疗下肢浅静脉曲张的操作流程,经中国微循环学会周围血管疾病专业委员会组织国内血管外科专家多次讨论,就治疗具体细节进行深入探讨,并结合该, cover=https://img.medsci.cn/20201027/1603730398681_2020535.jpg, journalId=0, articlesId=null, associationId=1457, associationName=中国微循环学会, associationIntro=, copyright=0, guiderPublishedTime=Tue Oct 20 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>聚桂醇作为泡沫硬化剂在临床已被广泛使用。为进一步规范聚桂醇泡沫硬化治疗下肢浅静脉曲张的操作流程,经中国微循环学会周围血管疾病专业委员会组织国内血管外科专家多次讨论,就治疗具体细节进行深入探讨,并结合该疾病硬化治疗的国内现状,参考国内、外相关资料,委托中国医学科学院北京协和医学院北京协和医院血管外科就下肢静脉曲张硬化治疗的基本概念、诊断和治疗操作规范等方面达成《聚桂醇注射液治疗下肢静脉曲张微循环专家共识(2020 版)》,供临床参考使用。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=15207, tagName=静脉曲张)], categoryList=[CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=92, categoryName=血管外科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=15207, guiderKeyword=静脉曲张, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=7667, appHits=204, showAppHits=0, pcHits=748, showPcHits=7463, likes=3, shares=13, comments=17, approvalStatus=1, publishedTime=Tue Oct 27 00:40:14 CST 2020, publishedTimeString=2020-10-20, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Tue Oct 27 00:40:04 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Fri Jan 05 05:35:05 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=聚桂醇注射液治疗下肢静脉曲张微循环专家共识_.pdf)])
聚桂醇注射液治疗下肢静脉曲张微循环专家共识_.pdf
下载请点击:
评论区 (15)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1071707, encodeId=e97c10e17071d, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbb55483145, createdName=charly, createdTime=Fri Nov 19 10:45:34 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011737, encodeId=aca91011e3741, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09d55447382, createdName=ms2000002074214464, createdTime=Thu Aug 26 16:54:45 CST 2021, time=2021-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010368, encodeId=d9a31010368b0, content=111, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fa15580881, createdName=ms2000002132479092, createdTime=Sun Aug 22 19:30:51 CST 2021, time=2021-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968040, encodeId=73a396804034, content=好文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210521/39805f6cf9fc4f4ab1c51a45735c7b02/dab272923f7540668d6a78dbd24a26a8.jpg, createdBy=71515505707, createdName=年轻心脏02, createdTime=Sun May 23 23:17:58 CST 2021, time=2021-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967412, encodeId=458696e412d0, content=日益更新, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e494343625, createdName=13fe7a1cm07暂无昵称, createdTime=Fri May 21 10:21:27 CST 2021, time=2021-05-21, status=1, ipAttribution=)]
    2021-11-19 charly

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1071707, encodeId=e97c10e17071d, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbb55483145, createdName=charly, createdTime=Fri Nov 19 10:45:34 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011737, encodeId=aca91011e3741, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09d55447382, createdName=ms2000002074214464, createdTime=Thu Aug 26 16:54:45 CST 2021, time=2021-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010368, encodeId=d9a31010368b0, content=111, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fa15580881, createdName=ms2000002132479092, createdTime=Sun Aug 22 19:30:51 CST 2021, time=2021-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968040, encodeId=73a396804034, content=好文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210521/39805f6cf9fc4f4ab1c51a45735c7b02/dab272923f7540668d6a78dbd24a26a8.jpg, createdBy=71515505707, createdName=年轻心脏02, createdTime=Sun May 23 23:17:58 CST 2021, time=2021-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967412, encodeId=458696e412d0, content=日益更新, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e494343625, createdName=13fe7a1cm07暂无昵称, createdTime=Fri May 21 10:21:27 CST 2021, time=2021-05-21, status=1, ipAttribution=)]
    2021-08-26 ms2000002074214464

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1071707, encodeId=e97c10e17071d, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbb55483145, createdName=charly, createdTime=Fri Nov 19 10:45:34 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011737, encodeId=aca91011e3741, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09d55447382, createdName=ms2000002074214464, createdTime=Thu Aug 26 16:54:45 CST 2021, time=2021-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010368, encodeId=d9a31010368b0, content=111, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fa15580881, createdName=ms2000002132479092, createdTime=Sun Aug 22 19:30:51 CST 2021, time=2021-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968040, encodeId=73a396804034, content=好文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210521/39805f6cf9fc4f4ab1c51a45735c7b02/dab272923f7540668d6a78dbd24a26a8.jpg, createdBy=71515505707, createdName=年轻心脏02, createdTime=Sun May 23 23:17:58 CST 2021, time=2021-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967412, encodeId=458696e412d0, content=日益更新, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e494343625, createdName=13fe7a1cm07暂无昵称, createdTime=Fri May 21 10:21:27 CST 2021, time=2021-05-21, status=1, ipAttribution=)]
    2021-08-22 ms2000002132479092

    111

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1071707, encodeId=e97c10e17071d, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbb55483145, createdName=charly, createdTime=Fri Nov 19 10:45:34 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011737, encodeId=aca91011e3741, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09d55447382, createdName=ms2000002074214464, createdTime=Thu Aug 26 16:54:45 CST 2021, time=2021-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010368, encodeId=d9a31010368b0, content=111, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fa15580881, createdName=ms2000002132479092, createdTime=Sun Aug 22 19:30:51 CST 2021, time=2021-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968040, encodeId=73a396804034, content=好文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210521/39805f6cf9fc4f4ab1c51a45735c7b02/dab272923f7540668d6a78dbd24a26a8.jpg, createdBy=71515505707, createdName=年轻心脏02, createdTime=Sun May 23 23:17:58 CST 2021, time=2021-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967412, encodeId=458696e412d0, content=日益更新, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e494343625, createdName=13fe7a1cm07暂无昵称, createdTime=Fri May 21 10:21:27 CST 2021, time=2021-05-21, status=1, ipAttribution=)]
    2021-05-23 年轻心脏02

    好文章

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1071707, encodeId=e97c10e17071d, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbb55483145, createdName=charly, createdTime=Fri Nov 19 10:45:34 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011737, encodeId=aca91011e3741, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09d55447382, createdName=ms2000002074214464, createdTime=Thu Aug 26 16:54:45 CST 2021, time=2021-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010368, encodeId=d9a31010368b0, content=111, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fa15580881, createdName=ms2000002132479092, createdTime=Sun Aug 22 19:30:51 CST 2021, time=2021-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968040, encodeId=73a396804034, content=好文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210521/39805f6cf9fc4f4ab1c51a45735c7b02/dab272923f7540668d6a78dbd24a26a8.jpg, createdBy=71515505707, createdName=年轻心脏02, createdTime=Sun May 23 23:17:58 CST 2021, time=2021-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967412, encodeId=458696e412d0, content=日益更新, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e494343625, createdName=13fe7a1cm07暂无昵称, createdTime=Fri May 21 10:21:27 CST 2021, time=2021-05-21, status=1, ipAttribution=)]
    2021-05-21 13fe7a1cm07暂无昵称

    日益更新

    0